NCT01255696View on ClinicalTrials.gov

Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2011

Conditions
Celiac Disease
Interventions
BIOLOGICAL

ALV003

BIOLOGICAL

ALV003 placebo

Trial Locations (3)

Unknown

Terveystalo Kuopio, Kuopio

Oulu Diakonissalaitos (ODL), Oulu

FINN-MEDI Research Oy - Clinical Trials Center, Tampere

Sponsors
All Listed Sponsors
lead

Alvine Pharmaceuticals Inc.

INDUSTRY

NCT01255696 - Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease | Biotech Hunter | Biotech Hunter